Evidence map›Paper›PMID 41490258›Full record

ArticlePloS one2026

Integrating simulated and experimental data to identify mitochondrial bioenergetic defects in Parkinson's Disease models.

Sandeep Chenna, Alvin Joselin, Pierre Theurey, Daniele Bano, Paola Pizzo, Maria Ankarcrona, David S Park, Jochen H Prehn, Niamh M C Connolly

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sandeep ChennaCentre for Systems Medicine, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID https://orcid.org/0000-0003-2297-7691
Alvin JoselinDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.ORCID https://orcid.org/0000-0002-9010-0421
Pierre TheureyDepartment of Biomedical Sciences, and Centro Studi per la Neurodegenerazione (CESNE), University of Padua, Padua, Italy.
Daniele BanoGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Paola PizzoDepartment of Biomedical Sciences, and Centro Studi per la Neurodegenerazione (CESNE), University of Padua, Padua, Italy.
Maria AnkarcronaCenter for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
David S ParkDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Jochen H PrehnCentre for Systems Medicine, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID https://orcid.org/0000-0003-3479-7794
Niamh M C ConnollyCentre for Systems Medicine, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID https://orcid.org/0000-0002-6005-1307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial bioenergetics are vital for ATP production and are associated with several diseases, including Parkinson's Disease (PD). Here, we simulated a computational model of mitochondrial ATP production to interrogate mitochondrial bioenergetics under physiological and pathophysiological conditions, and provide a data resource that can be used to interpret mitochondrial bioenergetics experiments. We first characterised the impact of several common electron transport chain (ETC) impairments on experimentally-observable bioenergetic parameters. We then established an analysis pipeline to integrate simulations with experimental data and predict the molecular defects underlying experimental bioenergetic phenotypes. We applied the pipeline to data from PD models. We verified that the impaired bioenergetic profile previously measured in Parkin knockout (KO) neurons can be explained by increased mitochondrial uncoupling. We then generated primary cortical neurons from a Pink1 KO mouse model of PD, and measured reduced oxygen consumption rate (OCR) capacity and increased resistance to Complex III inhibition. Here, our pipeline predicted that multiple impairments are required to explain this bioenergetic phenotype. Finally, we provide all simulated data as a user-friendly resource that can be used to interpret mitochondrial bioenergetics experiments, predict underlying molecular defects, and inform experimental design.

Indexed as

Energy MetabolismMitochondriaParkinson DiseaseAdenosine TriphosphateAnimalsComputer SimulationDisease Models, AnimalHumansMiceMice, KnockoutNeuronsOxygen ConsumptionProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein LigasesAdenosine Triphosphateparkin proteinProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein Ligases

Identifiers

PMID41490258
PMCPMC12768341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.